AET - CVS Health: Surviving Amazon
CVS Health (CVS) started 2018 at multi-year lows on re-emergence of the fears of Amazon (AMZN) entering the online drugs market. My previous research last June questioned the reality of this threat with data suggesting that patients needed to spend more time with pharmacists, not less.
Due in part to the Amazon threat, CVS made a deal to purchase Aetna (AET) in a deal valued at $69 billion that sent the stock even lower recently. Quickly viewing how Walmart (WMT) traded in 2017 suggests the pharmacy company